Disruptive innovation within Neuromodulation! 3 in a row, after Inceptiv, Synchromed III now it’s the time to change the game in DBS. More options for clinicians and patients! #Medtronicemployee #Proudtobemedtronic #Gamechangersinneuromodulation
This week marks another groundbreaking milestone for all of us at Medtronic. We are once again engineering the extraordinary to help those with Parkinson’s Disease, Essential Tremor, Dystonia and Epilepsy benefit from our purposeful and tireless pursuit for innovation with impact. We are proud to announce the Percept™ RC rechargeable neurostimulator has received CE Mark. With Percept™ RC we continue to shape the future of Brain Modulation through sensing-enabled DBS, allowing clinicians to adapt DBS therapy to patients’ evolving needs. Please join me in congratulating the @Medtronic Brain Modulation team for their unwavering dedication to bring this life-changing technology to patients. Note: The Percept™ RC DBS system is not approved by the FDA for commercial use in the United States. See risk information: https://bit.ly/3t60kVC #medtronicemployee